Skye Bioscience, Inc. Investment Income, Interest
Skye Bioscience, Inc. (SKYE) reported Investment Income, Interest of $103.21 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- Skye Bioscience, Inc. investment income, interest for the quarter ending 2026-06-30 was $103.21K, a 80.64% decline year-over-year.
- Skye Bioscience, Inc. investment income, interest for the quarter ending 2026-03-31 was $169.62K, a 72.60% decline year-over-year.
- Skye Bioscience, Inc. investment income, interest for the quarter ending 2025-12-31 was $274.10K, a 62.57% decline year-over-year.
- Skye Bioscience, Inc. investment income, interest for the quarter ending 2025-09-30 was $418.47K, a 53.90% decline year-over-year.
- Skye Bioscience, Inc. investment income, interest for fiscal 2025 was $1.88M, a 37.80% decline from fiscal 2024.
- Skye Bioscience, Inc. investment income, interest for fiscal 2024 was $3.03M, a 2929.55% increase from fiscal 2023.
- Skye Bioscience, Inc. investment income, interest for fiscal 2023 was $99.97K, a 425.87% increase from fiscal 2022.
- Skye Bioscience, Inc. investment income, interest for fiscal 2022 was $19.01K, a 633600.00% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 25 month | Investment Income, Interest 29 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $103.21K 10-Q · filed 2026-08-14 | $272.82K 10-Q · filed 2026-08-14 | $546.92K derived: sum of 3 quarters · filed 2026-08-14 | $965.39K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $169.62K 10-Q · filed 2026-05-11 | $443.71K derived: sum of 2 quarters · filed 2026-05-11 | $862.18K derived: sum of 3 quarters · filed 2026-05-11 | $1.40M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $274.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $692.57K derived: sum of 2 quarters · filed 2026-03-10 | $1.23M derived: sum of 3 quarters · filed 2026-08-14 | $1.88M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $418.47K 10-Q · filed 2025-11-10 | $951.56K derived: sum of 2 quarters · filed 2026-08-14 | $1.61M 10-Q · filed 2025-11-10 | $2.30M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $533.09K 10-Q · filed 2026-08-14 | $1.19M 10-Q · filed 2026-08-14 | $1.88M derived: sum of 3 quarters · filed 2026-08-14 | $2.79M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $619.05K 10-Q · filed 2026-05-11 | $1.35M derived: sum of 2 quarters · filed 2026-05-11 | $2.26M derived: sum of 3 quarters · filed 2026-05-11 | $3.22M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $732.27K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.64M derived: sum of 2 quarters · filed 2026-03-10 | $2.60M derived: sum of 3 quarters · filed 2026-03-10 | $3.03M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $907.70K 10-Q · filed 2025-11-10 | $1.87M derived: sum of 2 quarters · filed 2025-11-10 | $2.30M 10-Q · filed 2025-11-10 | $2.35M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $961.24K 10-Q · filed 2025-08-07 | $1.39M 10-Q · filed 2025-08-07 | $1.44M derived: sum of 3 quarters · filed 2025-08-07 | $1.46M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $427.55K 10-Q · filed 2025-05-08 | $426.51K 10-Q · filed 2024-05-10 | $477.86K derived: sum of 2 quarters · filed 2025-05-08 | $494.42K derived: sum of 3 quarters · filed 2025-05-08 | $503.02K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $50.30K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $66.87K derived: sum of 2 quarters · filed 2025-03-20 | $75.47K derived: sum of 3 quarters · filed 2025-03-20 | $99.97K 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $16.56K 10-Q · filed 2024-11-07 | $25.16K derived: sum of 2 quarters · filed 2024-11-07 | $49.67K 10-Q · filed 2024-11-07 | $68.69K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $8.60K 10-Q · filed 2024-08-09 | $33.11K 10-Q · filed 2024-08-09 | $52.12K derived: sum of 3 quarters · filed 2024-08-09 | $52.12K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $24.51K 10-Q · filed 2024-05-10 | $43.52K derived: sum of 2 quarters · filed 2024-05-10 | $43.52K derived: sum of 3 quarters · filed 2024-05-10 | $43.52K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $19.01K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $19.01K derived: sum of 2 quarters · filed 2024-03-22 | $19.01K derived: sum of 3 quarters · filed 2024-03-22 | $19.01K 10-K · filed 2024-03-22 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | |||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | $3.00 10-K · filed 2023-03-31 | ||||||
| 2020-12-31 | $29.00 10-K · filed 2022-03-28 | ||||||
| 2019-12-31 | $26.00 10-K · filed 2021-03-02 | ||||||
| 2018-12-31 | $10.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $10.00 derived: sum of 2 quarters · filed 2020-03-23 | $84.00 derived: sum of 3 quarters · filed 2020-03-23 | $84.00 10-K · filed 2020-03-23 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $74.00 derived: sum of 2 quarters · filed 2018-11-14 | $74.00 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | $74.00 10-Q · filed 2018-08-10 | $74.00 10-Q · filed 2018-08-10 | |||||
| 2014-07-31 | $587.00 10-Q · filed 2014-09-15 | $811.00 derived: sum of 2 quarters · filed 2014-09-15 | $1.22K 10-Q · filed 2014-09-15 | $1.61K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2014-04-30 | $224.00 10-Q · filed 2014-06-05 | $632.00 10-Q · filed 2014-06-05 | $1.02K derived: sum of 3 quarters · filed 2014-06-05 | $1.12K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2014-01-31 | $407.00 10-Q · filed 2014-03-17 | $798.00 derived: sum of 2 quarters · filed 2014-03-17 | $892.00 derived: sum of 3 quarters · filed 2014-09-15 | $1.05K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2013-10-31 | $391.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $485.00 derived: sum of 2 quarters · filed 2014-09-15 | $647.00 derived: sum of 3 quarters · filed 2014-09-15 | $789.00 10-K · filed 2014-01-27 | |||
| 2013-07-31 | $94.00 10-Q · filed 2014-09-15 | $256.00 derived: sum of 2 quarters · filed 2014-09-15 | $398.00 10-Q · filed 2014-09-15 | $541.00 derived: sum of 4 quarters · filed 2014-09-15 | $1.58K 10-Q · filed 2013-09-16 | ||
| 2013-04-30 | $162.00 10-Q · filed 2014-06-05 | $305.00 10-Q · filed 2014-06-05 | $447.00 derived: sum of 3 quarters · filed 2014-06-05 | $595.00 derived: sum of 4 quarters · filed 2014-06-05 | $1.49K 10-Q · filed 2013-06-27 | ||
| 2013-01-31 | $143.00 10-Q · filed 2014-03-17 | $285.00 derived: sum of 2 quarters · filed 2014-03-17 | $433.00 derived: sum of 3 quarters · filed 2014-03-17 | $602.00 derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-10-31 | $142.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $290.00 derived: sum of 2 quarters · filed 2014-01-27 | $459.00 derived: sum of 3 quarters · filed 2014-01-27 | $638.00 10-K · filed 2014-01-27 | |||
| 2012-07-31 | $148.00 10-Q · filed 2013-09-16 | $317.00 derived: sum of 2 quarters · filed 2013-09-16 | $496.00 10-Q · filed 2013-09-16 | ||||
| 2012-04-30 | $169.00 10-Q · filed 2013-06-27 | $348.00 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |